CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation

Journal of Immunology

Volumn 186, Issue 8, 2011, Pages 4835-4844

  Garaud, Soizic ^a   Morva, Ahsen ^a   Lemoine, Sébastien ^a   Hillion, Sophie ^a   Bordron, Anne ^a   Pers, Jacques Olivier ^a,b   Berthou, Christian ^a   Mageed, Rizgar A ^a   Renaudineau, Yves ^a,b   Youinou, Pierre ^a,b  

^a Universite de Brest   (France)

^b UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; COMPLEMENTARY DNA; INTERLEUKIN 10; INTERLEUKIN 3; INTERLEUKIN 5; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT 2; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL NUCLEUS TRANSPLANTATION; CHROMATIN IMMUNOPRECIPITATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXON; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD5; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; CHILD; FEMALE; GENE EXPRESSION; HEP G2 CELLS; HUMANS; INFANT, NEWBORN; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-5; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NFATC TRANSCRIPTION FACTORS; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SERINE; STAT3 TRANSCRIPTION FACTOR;

EID: 79955049815     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003050     Document Type: Article

References (50)

1. Chiorazzi, N., K. R. Rai, and M. Ferrarini. 2005. Chronic lymphocytic leukemia. N. Engl. J. Med. 352:804-815.
2. Messmer, B. T., D. Messmer, S. L. Allen, J. E. Kolitz, P. Kudalkar, D. Cesar, E. J. Murphy, P. Koduru, M. Ferrarini, S. Zupo, et al. 2005. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J. Clin. Invest. 115:755-764. (Pubitemid 40322252)
3. Smit, L. A., D. Y. Hallaert, R. Spijker, B. de Goeij, A. Jaspers, A. P. Kater, M. H. van Oers, C. J. van Noesel, and E. Eldering. 2007. Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity. Blood 109:1660-1668. (Pubitemid 46242110)
4. Gary-Gouy, H., J. Harriague, G. Bismuth, C. Platzer, C. Schmitt, and A. H. Dalloul. 2002. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 100:4537-4543. (Pubitemid 35429695)
5. Renaudineau, Y., S. Hillion, A. Saraux, R. A. Mageed, and P. Youinou. 2005. An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes. Blood 106:2781-2789. (Pubitemid 41510754)
6. Renaudineau, Y., S. Vallet, C. Le Dantec, S. Hillion, A. Saraux, and P. Youinou. 2005. Characterization of the human CD5 endogenous retrovirus-E in B lymphocytes. Genes Immun. 6:663-671. (Pubitemid 41741711)
7. Garaud, S., C. Le Dantec, C. Berthou, P. M. Lydyard, P. Youinou, and Y. Renaudineau. 2008. Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes. J. Immunol. 181:2010-2018.
8. Garaud, S., C. Le Dantec, A. R. de Mendoza, R. A. Mageed, P. Youinou, and Y. Renaudineau. 2009. IL-10 production by B cells expressing CD5 with the alternative exon 1B. Ann. N. Y. Acad. Sci. 1173:280-285.
9. Jurlander, J., C. F. Lai, J. Tan, C. C. Chou, C. H. Geisler, J. Schriber, L. E. Blumenson, S. K. Narula, H. Baumann, and M. A. Caligiuri. 1997. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood 89:4146-4152. (Pubitemid 27220963)
10. Gary-Gouy, H., A. Sainz-Perez, J. B. Marteau, A. Marfaing-Koka, J. Delic, H. Merle-Beral, P. Galanaud, and A. H. Dalloul. 2007. Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype. J. Immunol. 179:4335-4344.
11. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765. (Pubitemid 32368050)
12. Burdin, N., F. Rousset, and J. Banchereau. 1997. B-cell-derived IL-10: production and function. Methods 11:98-111. (Pubitemid 27207921)
13. Garaud, S., C. Le Dantec, S. Jousse-Joulin, C. Hanrotel-Saliou, A. Saraux, R. A. Mageed, P. Youinou, and Y. Renaudineau. 2009. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J. Immunol. 182:5623-5632.
14. Harris, D. P., L. Haynes, P. C. Sayles, D. K. Duso, S. M. Eaton, N. M. Lepak, L. L. Johnson, S. L. Swain, and F. E. Lund. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1:475-482.
15. Llorente, L., W. Zou, Y. Levy, Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, B. Morel-Fourrier, J. C. Brouet, D. Alarcón-Segovia, P. Galanaud, and D. Emilie. 1995. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181:839-844.
16. Defrance, T., B. Vanbervliet, F. Brière, I. Durand, F. Rousset, and J. Banchereau. 1992. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175:671-682.
17. Kitabayashi, A., M. Hirokawa, and A. B. Miura. 1995. The role of interleukin-10 (IL-10) in chronic B-lymphocytic leukemia: IL-10 prevents leukemic cells from apoptotic cell death. Int. J. Hematol. 62:99-106.
18. Fayad, L., M. J. Keating, J. M. Reuben, S. O'Brien, B. N. Lee, S. Lerner, and R. Kurzrock. 2001. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood 97:256-263. (Pubitemid 32061268)
19. Murray, P. J. 2007. The JAK-STAT signaling pathway: input and output integration. J. Immunol. 178:2623-2629. (Pubitemid 46333135)
20. Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707-747. (Pubitemid 27169297)
21. Ding, B. B., J. J. Yu, R. Y. Yu, L. M. Mendez, R. Shaknovich, Y. Zhang, G. Cattoretti, and B. H. Ye. 2008. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. Blood 111:1515-1523. (Pubitemid 351213441)
22. Park, J., N. R. Yaseen, P. G. Hogan, A. Rao, and S. Sharma. 1995. Phosphorylation of the transcription factor NFATp inhibits its DNA binding activity in cyclosporin A-treated human B and T cells. J. Biol. Chem. 270:20653-20659.
23. Matutes, E., and D. Catovsky. 1994. The value of scoring systems for the diagnosis of biphenotypic leukemia and mature B-cell disorders. Leuk. Lymphoma 13 (Suppl. 1):11-14. (Pubitemid 24158934)
24. Binet, J. L., A. Auquier, G. Dighiero, C. Chastang, H. Piguet, J. Goasguen, G. Vaugier, G. Potron, P. Colona, F. Oberling, et al. 1981. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198-206. (Pubitemid 11064396)
25. Hamblin, T. J., J. A. Orchard, R. E. Ibbotson, Z. Davis, P. W. Thomas, F. K. Stevenson, and D. G. Oscier. 2002. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 99:1023-1029. (Pubitemid 34525567)
26. Findley, H. W., Jr., M. D. Cooper, T. H. Kim, C. Alvarado, and A. H. Ragab. 1982. Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes. Blood 60:1305-1309. (Pubitemid 13211367)
27. -δδC (T) Method. Methods 25:402-408. (Pubitemid 34164012)
28. Frank, D. A., S. Mahajan, and J. Ritz. 1997. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. J. Clin. Invest. 100:3140-3148. (Pubitemid 28022852)
29. Lee, C. G., K. H. Kang, J. S. So, H. K. Kwon, J. S. Son, M. K. Song, A. Sahoo, H. J. Yi, K. C. Hwang, T. Matsuyama, et al. 2009. A distal cis-regulatory element, CNS-9, controls NFAT1 and IRF4-mediated IL-10 gene activation in T helper cells. Mol. Immunol. 46:613-621.
30. Oku, S., K. Takenaka, T. Kuriyama, K. Shide, T. Kumano, Y. Kikushige, S. Urata, T. Yamauchi, C. Iwamoto, H. K. Shimoda, et al. 2010. JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation. Br. J. Haematol. 150:334-344.
31. De Boer, M. L., V. A. Mordvinov, M. A. Thomas, and C. J. Sanderson. 1999. Role of nuclear factor of activated T cells (NFAT) in the expression of interleukin-5 and other cytokines involved in the regulation of hemopoetic cells. Int. J. Biochem. Cell Biol. 31:1221-1236. (Pubitemid 29454556)
32. Monticelli, S., D. C. Solymar, and A. Rao. 2004. Role of NFAT proteins in IL13 gene transcription in mast cells. J. Biol. Chem. 279:36210-36218. (Pubitemid 39128956)
33. Lavabre-Bertrand, T., G. Janossy, C. Exbrayat, P. Bourquard, C. Duperray, and M. Navarro. 1994. Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL. Leukemia 8:1557-1563. (Pubitemid 24293663)
34. Yen Chong, S., Y. C. Lin, J. Czarneski, M. Zhang, F. Coffman, F. Kashanchi, and E. Raveche. 2001. Cell cycle effects of IL-10 on malignant B-1 cells. Genes Immun. 2:239-247. (Pubitemid 33681705)
35. McCarthy, B. A., A. Mansour, Y. C. Lin, S. Kotenko, and E. Raveche. 2004. RNA interference of IL-10 in leukemic B-1 cells. Cancer Immun. 4:6.
36. Karras, J. G., Z. Wang, L. Huo, R. G. Howard, D. A. Frank, and T. L. Rothstein. 1997. Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J. Exp. Med. 185:1035-1042. (Pubitemid 27136796)
37. Qin, H. R., H. J. Kim, J. Y. Kim, E. M. Hurt, G. J. Klarmann, B. T. Kawasaki, M. A. Duhagon Serrat, and W. L. Farrar. 2008. Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation. Cancer Res. 68:7736-7741.
38. Staples, K. J., T. Smallie, L. M. Williams, A. Foey, B. Burke, B. M. Foxwell, and L. Ziegler-Heitbrock. 2007. IL-10 induces IL-10 in primary human monocytederived macrophages via the transcription factor Stat3. J. Immunol. 178:4779-4785. (Pubitemid 46595259)
39. Schuh, K., A. Avots, H. P. Tony, E. Serfling, and C. Kneitz. 1996. Nuclear NF-ATp is a hallmark of unstimulated B cells from B-CLL patients. Leuk. Lymphoma 23:583-592. (Pubitemid 27029670)
40. Hazan-Halevy, I., D. Harris, Z. Liu, J. Liu, P. Li, X. Chen, S. Shanker, A. Ferrajoli, M. J. Keating, and Z. Estrov. 2010. STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells. Blood 115:2852-2863.
41. Monticelli, S., and A. Rao. 2002. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur. J. Immunol. 32:2971-2978. (Pubitemid 35238190)
42. Benkhart, E. M., M. Siedlar, A. Wedel, T. Werner, and H. W. Ziegler-Heitbrock. 2000. Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression. J. Immunol. 165:1612-1617. (Pubitemid 30604599)
43. Unterberger, C., K. J. Staples, T. Smallie, L. Williams, B. Foxwell, A. Schaefer, B. Kempkes, T. P. Hofer, M. Koeppel, M. Lohrum, et al. 2008. Role of STAT3 in glucocorticoid-induced expression of the human IL-10 gene. Mol. Immunol. 45:3230-3237.
44. O'Garra, A., R. Chang, N. Go, R. Hastings, G. Haughton, and M. Howard. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22:711-717.
45. + phenotype controls T cell-dependent inflammatory responses. Immunity 28:639-650. (Pubitemid 351636247)
46. Ishida, H., R. Hastings, J. Kearney, and M. Howard. 1992. Continuous antiinterleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J. Exp. Med. 175:1213-1220.
47. Pers, J. O., C. Jamin, P. Youinou, and J. Charreire. 2003. Role of IL-10 in the distribution of B cell subsets in the mouse B-1 cell population. Eur. Cytokine Netw. 14:178-185. (Pubitemid 37249239)
48. Muzio, M., B. Apollonio, C. Scielzo, M. Frenquelli, I. Vandoni, V. Boussiotis, F. Caligaris-Cappio, and P. Ghia. 2008. Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood 112:188-195.
49. Pers, J. O., C. Berthou, N. Porakishvili, M. Burdjanadze, G. Le Calvez, J. F. Abgrall, P. M. Lydyard, P. Youinou, and C. Jamin. 2002. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia. Leukemia 16:44-52. (Pubitemid 34105598)
50. Kiani, A., A. Rao, and J. Aramburu. 2000. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 12:359-372.